방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 쉴트 분석× | 집단 약력학 모델링× | |
|---|---|---|
| 분야 | 약리학 | 약리학 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1947 | 1992 |
| 창시자≠ | Henry Schild | Lewis Sheiner and Stephen Roush |
| 유형≠ | antagonism quantification | dose-response modeling |
| 원전≠ | Schild, H. O. (1947). pA, a new scale for the measurement of drug antagonism. Journal of Physiology, 106(3), 337-357. DOI ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| 별칭≠ | Schild plot, pA2 | PopPD, population PD, hierarchical PD modeling |
| 관련 | 3 | 3 |
| 요약≠ | Schild analysis is a quantitative method for characterizing competitive receptor antagonism developed by Henry Schild in 1947. It uses dose-response curves in the presence and absence of antagonist to estimate the antagonist affinity constant (pA2), enabling standardized comparison of antagonist potency across drugs and experimental systems. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGate데이터셋 ↗ |
|
|